Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MTOR | P42345 | 17/20 | 0.52 |
| ▸ | HDAC1 | Q13547 | 7/20 | 0.52 |
| ▸ | HDAC3 | O15379 | 2/20 | 0.52 |
| ▸ | HDAC2 | Q92769 | 2/20 | 0.52 |
| ▸ | HDAC8 | Q9BY41 | 2/20 | 0.52 |
| ▸ | HDAC6 | Q9UBN7 | 2/20 | 0.52 |
| ▸ | PIK3CD | O00329 | 4/20 | 0.51 |
| ▸ | PIK3CA | P42336 | 4/20 | 0.51 |
| ▸ | PIK3CG | P48736 | 4/20 | 0.51 |
| ▸ | PIK3CB | P42338 | 3/20 | 0.51 |
| ▸ | ABL1 | P00519 | 2/20 | 0.51 |
| ▸ | PRKDC | P78527 | 2/20 | 0.49 |
| ▸ | DDR1 | Q08345 | 2/20 | 0.49 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30740011 | 0.93 | MTOR (0.58) | MTORHDAC1HDAC3HDAC2HDAC8 | |
| SCHEMBL20553360 | 0.93 | MTOR (0.58) | MTORHDAC1HDAC3HDAC2HDAC8 | |
| SCHEMBL29867929 | 0.93 | MTOR (0.58) | MTORHDAC1HDAC3HDAC2HDAC8 | |
| SCHEMBL31046941 | 0.85 | MTOR (0.48) | MTORHDAC1HDAC3HDAC2HDAC8 | |
| SCHEMBL21528068 | 0.85 | MTOR (0.48) | MTORHDAC1HDAC3HDAC2HDAC8 | |
| SCHEMBL23251625 | 0.83 | MTOR (0.62) | MTORHDAC1HDAC3HDAC2HDAC8 | |
| SCHEMBL21527989 | 0.83 | MTOR (0.51) | MTORHDAC1HDAC3HDAC2HDAC8 | |
| SCHEMBL30805610 | 0.83 | MTOR (0.51) | MTORHDAC1HDAC3HDAC2HDAC8 | |
| SCHEMBL23150559 | 0.82 | MTOR (0.63) | MTORHDAC1HDAC3HDAC2HDAC8 | |
| SCHEMBL29867532 | 0.82 | MTOR (0.56) | MTORHDAC1HDAC3HDAC2HDAC8 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4168002-A1 | METHODS FOR DELAYING, PREVENTING, AND TREATING ACQUIRED RESISTANCE TO RAS INHIBITORS | Revolution Medicines, Inc. (US) | 2023-04-26 | — | — | EP | disclosed |